Compass Therapeutics (CMPX) Other Gross PP&E Adjustments: 2023-2025
Historic Other Gross PP&E Adjustments for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to -$2.7 million.
- Compass Therapeutics' Other Gross PP&E Adjustments fell 1147.49% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.5 million, marking a year-over-year decrease of 164.81%. This contributed to the annual value of -$3.9 million for FY2024, which is 246.54% down from last year.
- Compass Therapeutics' Other Gross PP&E Adjustments amounted to -$2.7 million in Q3 2025, which was up 11.69% from -$3.1 million recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Other Gross PP&E Adjustments registered a high of $6.0 million during Q2 2024, and its lowest value of -$3.9 million during Q4 2024.
- Its 3-year average for Other Gross PP&E Adjustments is $1.8 million, with a median of $2.7 million in 2023.
- As far as peak fluctuations go, Compass Therapeutics' Other Gross PP&E Adjustments rose by 27.90% in 2024, and later tumbled by 1,147.49% in 2025.
- Quarterly analysis of 3 years shows Compass Therapeutics' Other Gross PP&E Adjustments stood at $2.7 million in 2023, then crashed by 246.54% to -$3.9 million in 2024, then slumped by 1,147.49% to -$2.7 million in 2025.
- Its Other Gross PP&E Adjustments was -$2.7 million in Q3 2025, compared to -$3.1 million in Q2 2025 and $225,000 in Q1 2025.